Sign In
Buy CTLT
$63.49
+0 (+0%)
At Close: Mar 14, 2025
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Catalent, Inc. - CTLT
10:00am, Saturday, 24'th Feb 2024
NEW YORK , Feb. 24, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Catalent, Inc. ("Catalent" or the "Company") (NYSE: CTLT). Such investors are advised to co
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Catalent, In
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Catalent, Inc. - CTLT
06:30pm, Thursday, 15'th Feb 2024
NEW YORK , Feb. 15, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Catalent, Inc. ("Catalent" or the "Company") (NYSE: CTLT). Such investors are advised to c
S&P 500's surge to new highs: Bull trap hiding in plain sight?
09:40am, Thursday, 15'th Feb 2024
The SPDR S&P 500 ETF Trust NYSEARCA: SPY is trading at new highs, but as the sharp pullback on February 13 showed, the rally may be showing signs of cracking.
Wegovy packing supplier Catalent lays off 300 workers
04:44pm, Wednesday, 14'th Feb 2024
Catalent has reduced its headcount by about 300 employees as part of its ongoing restructuring plans, the company disclosed in a regulatory filing on Wednesday.
Catalent (CTLT) Q2 Earnings Lag Estimates, Gross Margin Down
12:30pm, Friday, 09'th Feb 2024
Catalent (CTLT) reports lower revenues in Biologics segments in its second-quarter fiscal 2024, resulting in overall soft performance.
Catalent (CTLT) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
10:31am, Friday, 09'th Feb 2024
Although the revenue and EPS for Catalent (CTLT) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Str
Catalent Q2 sales inch past estimates amid takeover by Novo Holdings
09:25am, Friday, 09'th Feb 2024
Catalent reported second-quarter revenue slightly above Wall Street estimates on Friday, days after the contract drug manufacturer agreed to a $16.5-billion acquisition offer from Novo Nordisk's paren
Can financial, healthcare, energy stocks rise as rates stay high?
07:03am, Thursday, 08'th Feb 2024
Large bank stocks such as Berkshire Hathaway Inc. NYSE: BRK.B, JPMorgan Chase & Co. NYSE: JPM, and Citigroup Inc. NYSE: C are up in the past month as it's become clear that interest rates will remain
Novo Nordisk CEO on Catalent, Ozempic and Wegovy
02:06pm, Wednesday, 07'th Feb 2024
Novo Nordisk A/S CEO Lars Fruergaard Jorgensen discusses the company's acquisition of Catalent for for $16.5 billion and the production of its weight-loss drug Wegovy and diabetes treatment Ozempic. F
EU watchdog is looking into availability of drugs made at Catalent sites sold to Novo
12:32pm, Wednesday, 07'th Feb 2024
The European Union's drugs regulator said on Wednesday it will investigate any risks to the availability of medicines processed at Catalent sites that will be sold to Novo Nordisk , part of its mandat
Catalent (CTLT) Rides on Acquisition Offer From Novo Holdings
08:56am, Wednesday, 07'th Feb 2024
Catalent (CTLT) inks a merger agreement with Novo Holdings, under which the latter will acquire Catalent for $16.5 billion.
US FDA finds control lapses at Catalent plant being sold to Novo
05:23pm, Tuesday, 06'th Feb 2024
U.S. drug regulators in November found quality control lapses at the Bloomington, Indiana factory of contract drug manufacturer Catalent , including discovery of a "pest" on the manufacturing line, ac
Novo Nordisk acquisition of Catalent production sensible, analysts say
02:08pm, Tuesday, 06'th Feb 2024
Novo Nordisk (NYSE:NVO)'s takeover of three production sites through the acquisition of Catalent Inc (NYSE:CTLT) is a sensible move, analysts say, and will help meet demand for its flagship weight los
Strength Seen in Catalent (CTLT): Can Its 9.7% Jump Turn into More Strength?
07:21am, Tuesday, 06'th Feb 2024
Catalent (CTLT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the ro
